Author

Katarzyna A Rejniak

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Systems Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:simulation· 1 Research Focus:trajectory inference· 1

Frequent Co-Authors

Ami B Shah· 1 shared Damon R Reed· 1 shared Jana L Gevertz· 1 shared Marilyn M Bui· 1 shared Mark C Lloyd· 1 shared

Activity by Year

2015-2016 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 4 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Ami B Shah

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systems BiologybioRxivMar 4, 2016

Limiting the Development of Anti-Cancer Drug Resistance in a Spatial Model of Micrometastases

Ami B Shah, Katarzyna A Rejniak, Jana L Gevertz

This study uses a spatial model to show that certain fractionated-dose chemotherapy protocols are as effective as metronomic therapy in reducing micrometastases with acquired or pre-existing resistance.

DOI 10.3934/mbe.2016038

simulation

𝕏 PostBluesky

Systems BiologybioRxivJul 13, 2015

Diagnostic Assessment of Osteosarcoma Chemoresistance Based on Virtual Clinical Trials

Katarzyna A Rejniak, Mark C Lloyd, Damon R Reed, Marilyn M Bui

The paper develops a computational framework to predict osteosarcoma chemoresistance using pre-treatment biopsy data and virtual clinical trials.

DOI 10.1016/j.mehy.2015.06.015

humanbulk RNA-seq

𝕏 PostBluesky